Rethinking Cannabis: The Future of Metabolic Medicine

RETHINKING CANNABIS: THE FUTURE OF METABOLIC MEDICINE

Please join us for a special night featuring connection, conversation, and community.

March 4, 2026
6:30-8:00 PM
Location details provided upon RSVP

We’re excited to host Professor Yossi Tam—Managing Director of the Multidisciplinary Center on Cannabinoid Research and Head of the Obesity and Metabolism Laboratory at the Hebrew University of Jerusalem.

An informal evening hosted by Ronit and Zack Bodner (RIS ’94).

Enjoy drinks and light bites while reconnecting with fellow alumni, friends, and supporters of Hebrew University. Learn more about the AFHU Alumni Association and find out how you can get involved in events across the United States, virtual engagements with faculty, alumni missions to Israel, and more.

Response requested by March 1.

For any questions or more information:
📞 212.607.8506 | 📧[email protected] 

Please visit afhu.org/alumni and connect with us on Facebook and LinkedIn.

Dr. Yossi Tam, D.M.D., Ph.D., heads the Obesity and Metabolism Laboratory at the Hebrew University’s Institute for Drug Research and is the Director of the Multidisciplinary Center on Cannabinoid Research. The Center is focused on developing cannabinoid-based therapies to alleviate pain, treat traumatic brain injuries, and address a broad spectrum of diseases. Dr. Tam earned his B.S., M.S., Ph.D., and D.M.D. at Hebrew University and conducted his postdoctoral research fellowship in the U.S. at the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health (NIH), where he examined the biological mechanisms underlying obesity and metabolic syndrome. He joined the Hebrew University in 2011, where he began research on traumatic brain injuries that induce a systemic stimulation of bone formation, leading to excessive accumulation of bone. He has received numerous awards for his pioneering work, including the Jacob Metzner’s Young Investigators Award and the Fellows Award for Research Excellence (FARE) from the National Institutes of Health (NIH).